Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 15 Sep 2025 – 20 Aug 2026, limited by Axis Nifty500 Quality 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty500 Quality 50 Index Fund | Nifty 500 |
|---|---|---|
| 15 Sep 2025 | ₹100.00 | ₹100.00 |
| 13 Oct 2025 | ₹98.61 | ₹100.34 |
| 11 Nov 2025 | ₹99.28 | ₹102.01 |
| 09 Dec 2025 | ₹96.39 | ₹101.29 |
| 06 Jan 2026 | ₹97.80 | ₹103.42 |
| 03 Feb 2026 | ₹96.96 | ₹100.99 |
| 04 Mar 2026 | ₹91.03 | ₹96.53 |
| 01 Apr 2026 | ₹89.04 | ₹90.18 |
| 29 Apr 2026 | ₹100.39 | ₹98.51 |
| 27 May 2026 | ₹102.90 | ₹98.93 |
| 25 Jun 2026 | ₹100.23 | ₹99.56 |
| 23 Jul 2026 | ₹99.93 | ₹98.99 |
| 20 Aug 2026 | ₹101.78 | ₹101.28 |
| Metric | Axis · Regular NAV ₹10.20 Very High risk Unrated | Category median Index Funds · 366 funds |
|---|---|---|
| — | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +1.78% | +7.40% | |
| +7.80% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 15.97% | 13.88% | |
| — | 0.25 | |
| — | 0.35 | |
| -15.41% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.22% | 0.96% | |
| ₹78.06Cr | ₹182.17Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Karthik Kumar | — | |
| 15 Sep 2025 | — | |
| 50 | — | |
| 39.3% | — | |
| -0.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.